BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23221488)

  • 1. Acute mucocutaneous methotrexate toxicity associated with interface dermatitis and numerous eosinophils.
    Ferguson NN; Asarch A; VanBeek M; Swick BL
    Am J Dermatopathol; 2013 Jun; 35(4):e63-6. PubMed ID: 23221488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute mucocutaneous methotrexate toxicity with marked tissue eosinophilia.
    Borda LJ; Ross A; Villada G; Milikowski C
    BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29627775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage].
    Haber R; Baroudjian B; Battistella M; Bagot M; Petit A
    Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue.
    Fridlington JL; Tripple JW; Reichenberg JS; Hall CS; Diven DG
    Dermatol Online J; 2011 Nov; 17(11):2. PubMed ID: 22136858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
    Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
    Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose methotrexate induced asymptomatic keratinocyte dystrophy in a patient of psoriasis vulgaris.
    Behera B; Kumari R; Gochhait D; Thappa DM
    J Cutan Pathol; 2016 Dec; 43(12):1238-1241. PubMed ID: 27714834
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute methotrexate toxicity in psoriasis].
    Arévalo-López A
    Gac Med Mex; 1999; 135(5):513-6. PubMed ID: 10596492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
    Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
    Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucocutaneous ulcerations secondary to methotrexate.
    Warner J; Brown A; Whitmore SE; Cowan DA
    Cutis; 2008 May; 81(5):413-6. PubMed ID: 18543592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erosion of psoriatic plaques: an early sign of methotrexate toxicity.
    Pearce HP; Wilson BB
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 2):835-8. PubMed ID: 8912599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two contrasting post-zoster dermatomal phenomena.
    Sultan SJ; Sameem F
    Skinmed; 2012; 10(5):312-4. PubMed ID: 23163077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker.
    Delyon J; Ortonne N; Benayoun E; Moroch J; Wolkenstein P; Sbidian E; Chosidow O
    J Am Acad Dermatol; 2015 Sep; 73(3):484-90. PubMed ID: 26190242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate-induced papular eruption following treatment of psoriasis.
    Mebazaa A; Kenani N; Denguezli M; Ben Salem C; Ziadi S; Sriha B; Belajouza C; Nouira R
    Ann Pharmacother; 2008 Jan; 42(1):138-41. PubMed ID: 18094347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies.
    Laga AC; Vleugels RA; Qureshi AA; Velazquez EF
    Am J Dermatopathol; 2010 Aug; 32(6):568-73. PubMed ID: 20520526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate toxicity induced by ciprofloxacin leading to psoriatic plaque ulceration: a case report.
    Kamangar F; Berger TG; Fazel N; Koo JY
    Cutis; 2013 Sep; 92(3):148-50. PubMed ID: 24153144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate toxicity presenting as cutaneous ulcerations on psoriatic plaques.
    Koçak AY; Koçak O; Aslan F; Tektaş M
    Cutan Ocul Toxicol; 2013 Oct; 32(4):333-5. PubMed ID: 23537374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [4pp Mucocutaneous manifestations of methotrexate toxicity].
    Ferrari B; Kogan N; Veira RC; Luna PC; Larralde M; Cuesta MG; Díaz P; Rossi MV; Aloise I
    Medicina (B Aires); 2018; 78(1):50-53. PubMed ID: 29360079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema gyratum repens-like eruption occuring in resolving psoriasis during methotrexate therapy.
    Singal A; Sonthalia S; Pandhi D
    Int J Dermatol; 2010 Mar; 49(3):306-7. PubMed ID: 20465670
    [No Abstract]   [Full Text] [Related]  

  • 19. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features.
    Tetzlaff MT; Nagarajan P; Chon S; Huen A; Diab A; Omar P; Aung PP; Torres-Cabala CA; Mays SR; Prieto VG; Curry JL
    Am J Dermatopathol; 2017 Feb; 39(2):121-129. PubMed ID: 28134729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion.
    Yélamos O; Català A; Vilarrasa E; Roé E; Puig L
    Dermatology; 2014; 229(4):306-9. PubMed ID: 25401478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.